paperKB
coga / coga-kb
Help
Sign in

Chunk #16 — RESULTS — Validation of the optimized inducible knockdown platforms in differentiated progenies of hPSCs

Source
Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs.
Embedded
yes

Text

Interestingly, EGFP was less reduced in cell types with slower proliferation rates (Fig. S4A). Since EGFP has an extended half-life of more than 24 h, protein loss upon transcriptional or post-transcriptional inhibition relies heavily upon its gradual dilution following cell division (Li, 1998). Considering the strong decrease in EGFP mRNA, we concluded that residual EGFP fluorescence was likely to be a consequence of the relatively short tetracycline treatment performed to trigger knockdown (5 days). To test this, we induced prolonged EGFP knockdown in postmitotic cardiomyocytes, and we indeed observed a slow but constant decrease in protein expression for up to 20 days, at which point the EGFP was decreased by more than 75% (Fig. S4H,I). To reinforce these observations, we performed similar experiments using a ROSA26-targeted EGFP reporter transgene fused to a destabilization domain (EGFPd2; Li et al., 1998), which avoids confounding effects due to the long half-life of standard EGFP (Fig. S4J-M) (Wahlers et al., 2001). Remarkably, EGFPd2 inducible knockdown in cardiomyocytes using the sOPTiKD method resulted in >90% protein knockdown after 5 days of tetracycline treatment (Fig. S4N,O). Considered together, these results establish that OPTiKD and sOPTiKD allow efficient manipulation of gene expression even after differentiation of hPSCs.